TGFB1 and neoplasm: Mechanistically, miR-21 drives tumor progression by downregulating SMAD7 and MSH2 in the TGF-β pathway while upregulating human epidermal growth factor receptor 2, thereby functioning as an oncogene (Chen et al., 2013; Gong et al., 2011).